These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 18308246

  • 1. Biases in estimates of overdetection due to mammography screening.
    Zahl PH, Jørgensen KJ, Maehlen J, Gøtzsche PC.
    Lancet Oncol; 2008 Mar; 9(3):199-201; author reply 201-2. PubMed ID: 18308246
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Results of the Two-County trial of mammography screening are not compatible with contemporaneous official Swedish breast cancer statistics.
    Zahl PH, Gøtzsche PC, Andersen JM, Maehlen J.
    Dan Med Bull; 2006 Nov; 53(4):438-40. PubMed ID: 17150148
    [Abstract] [Full Text] [Related]

  • 4. Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.
    Weedon-Fekjær H, Bakken K, Vatten LJ, Tretli S.
    BMJ; 2012 Jan 30; 344():e299. PubMed ID: 22290099
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mammography screening: truth, lies, and controversy.
    Gøtzsche PC.
    Lancet; 2012 Jul 21; 380(9838):218. PubMed ID: 22817975
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mammography studies revisited.
    Emory TH.
    Minn Med; 2004 Feb 21; 87(2):7. PubMed ID: 15005121
    [No Abstract] [Full Text] [Related]

  • 9. Screening mammography in women 40 to 49 years of age: yes.
    Kopans DB.
    Important Adv Oncol; 1995 Feb 21; ():231-41. PubMed ID: 7672809
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?
    Hofvind S, Sakshaug S, Ursin G, Graff-Iversen S.
    Int J Cancer; 2012 Jun 15; 130(12):2930-8. PubMed ID: 21732346
    [Abstract] [Full Text] [Related]

  • 14. Diagnosing breast cancer at earlier stages of disease.
    Fulton JP, Donahue FA, Browning C.
    R I Med; 1994 Oct 15; 77(10):362. PubMed ID: 7803870
    [No Abstract] [Full Text] [Related]

  • 15. Summaries for patients: Overdiagnosis of invasive breast cancer with mammography screening.
    Ann Intern Med; 2012 Apr 03; 156(7):I58. PubMed ID: 22473444
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
    Hauge IH, Pedersen K, Olerud HM, Hole EO, Hofvind S.
    Acta Radiol; 2014 Dec 03; 55(10):1174-9. PubMed ID: 24311702
    [Abstract] [Full Text] [Related]

  • 18. Mammography screening and the increase in breast cancer incidence in Hawaii.
    Maskarinec G, Wilkens L, Meng L.
    Cancer Epidemiol Biomarkers Prev; 1997 Mar 03; 6(3):201-8. PubMed ID: 9138664
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.